🇺🇸 highly active antiretroviral therapy (HAART) in United States

highly active antiretroviral therapy (HAART) (highly active antiretroviral therapy (HAART)) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

highly active antiretroviral therapy (HAART) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is highly active antiretroviral therapy (HAART) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for highly active antiretroviral therapy (HAART) in United States?

National Institute of Allergy and Infectious Diseases (NIAID) is the originator. The local marketing authorisation holder may differ — check the official source linked above.